AK4P1: A Potent Drug Target and Potential Biomarker (G206)

Target Name: AK4P1

NCBI ID: G206

AK4P1

Other Name(s): Adenylate kinase 4 pseudogene 1 | AK3P1 | adenylate kinase 4 pseudogene 1

AK4P1: A Potent Drug Target and Potential Biomarker

AK4P1, also known as Adenylate Kinase 4 Pseudogene 1, is a gene that encodes a protein involved in cellular signaling pathways. The AK4P1 gene has been identified as a potential drug target and biomarker for various diseases, including cardiovascular, neurodegenerative, and psychiatric disorders. This article will provide an overview of AK4P1, its potential drug targeting, and its potential as a biomarker.

Overview of AK4P1 and Its Functions

AK4P1 is a 21-kDa protein that is expressed in various tissues, including muscle, heart, brain, and pancreas. It plays a critical role in regulating cellular signaling pathways, including the G protein-coupled receptor (GPCR) signaling pathway. This protein is involved in the regulation of various cellular processes, including cell growth, differentiation, and survival.

Drug Targeting andAK4P1's Potential as a Biomarker

AK4P1 has been identified as a potential drug target due to its involvement in various cellular signaling pathways. The GPCR signaling pathway, which is a critical pathway involved in the regulation of cellular behaviors, has been identified as a potential target for AK4P1. Several GPCR antagonists have been developed and are currently in use for various psychiatric and cardiovascular disorders. These drugs work by blocking the interaction between GPCRs and AK4P1, which results in the inhibition of cellular signaling.

In addition to its potential as a drug target, AK4P1 has also been identified as a potential biomarker for various diseases. TheAK4P1 gene has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. This suggests that AK4P1 may be a useful biomarker for the diagnosis and progression of certain diseases.

Expression of AK4P1 and Its Potential as a Biomarker

AK4P1 is highly expressed in various tissues and is involved in the regulation of various cellular processes. It is expressed in the brain, heart, and pancreas and has been shown to be involved in the regulation of neurotransmitter release, neurogenesis, and pancreatic function.

In addition to its expression in various tissues, AK4P1 has also been shown to be involved in the regulation of cellular signaling pathways. It is a GPCR target and has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and survival.

The Potential ofAK4P1 as a Drug Target

The potential of AK4P1 as a drug target is based on its involvement in the regulation of various cellular signaling pathways. The GPCR signaling pathway, which is involved in the regulation of cellular behaviors, has been identified as a potential target for AK4P1. Several GPCR antagonists have been developed and are currently in use for various psychiatric and cardiovascular disorders. These drugs work by blocking the interaction between GPCRs and AK4P1, which results in the inhibition of cellular signaling.

In addition to its potential as a drug target, AK4P1 has also been identified as a potential biomarker for various diseases. TheAK4P1 gene has been shown to be involved in the regulation of various cellular processes, including cell growth, differentiation, and survival. This suggests that AK4P1 may be a useful biomarker for the diagnosis and progression of certain diseases.

Conclusion

AK4P1 is a gene that encodes a protein involved in cellular signaling pathways. Its potential as a drug target and biomarker for various diseases has been identified based on its involvement in the regulation of various cellular signaling pathways, including the GPCR signaling pathway. Further research is needed to fully understand the potential of AK4P1 as a drug

Protein Name: Adenylate Kinase 4 Pseudogene 1

The "AK4P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AK4P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets